• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体:终生引导关键信号网络。

ErbB receptors: directing key signaling networks throughout life.

作者信息

Holbro Thomas, Hynes Nancy E

机构信息

Friedrich Miescher Institute for Biomedical Research, 4002 Basel, Switzerland.

出版信息

Annu Rev Pharmacol Toxicol. 2004;44:195-217. doi: 10.1146/annurev.pharmtox.44.101802.121440.

DOI:10.1146/annurev.pharmtox.44.101802.121440
PMID:14744244
Abstract

The epidermal growth factor (EGF)-related peptides bind the ErbB receptors, inducing the formation of different homo- and heterodimers. Receptor dimerization promotes activation of the intrinsic kinase, leading to phosphorylation of specific tyrosines located in the ErbB's cytoplasmic region. These phosphorylated residues serve as docking sites for a variety of signaling molecules whose recruitment stimulates intracellular signaling cascades, which ultimately control diverse genetic programs. Particular ligand-receptor complexes have essential roles in embryonic development as well as in the adult. Finally, ErbB receptors are being pursued as therapeutic targets because aberrant ErbB activity has been observed in many human cancers. In this review, we discuss these data in more detail, illustrating the importance of tightly regulated ErbB signaling throughout life.

摘要

表皮生长因子(EGF)相关肽与表皮生长因子受体(ErbB)结合,诱导形成不同的同二聚体和异二聚体。受体二聚化促进内在激酶的激活,导致位于ErbB胞质区域的特定酪氨酸磷酸化。这些磷酸化残基作为多种信号分子的停靠位点,这些信号分子的募集刺激细胞内信号级联反应,最终控制各种基因程序。特定的配体-受体复合物在胚胎发育以及成体中都起着至关重要的作用。最后,由于在许多人类癌症中都观察到ErbB活性异常,因此ErbB受体正被作为治疗靶点进行研究。在本综述中,我们将更详细地讨论这些数据,阐明在整个生命过程中严格调控ErbB信号传导的重要性。

相似文献

1
ErbB receptors: directing key signaling networks throughout life.表皮生长因子受体:终生引导关键信号网络。
Annu Rev Pharmacol Toxicol. 2004;44:195-217. doi: 10.1146/annurev.pharmtox.44.101802.121440.
2
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.通过金属蛋白酶介导的表皮生长因子样因子胞外域脱落来控制表皮生长因子受体(ErbB)信号传导
Growth Factors. 2006 Jun;24(2):121-36. doi: 10.1080/08977190600634373.
3
The neuregulin-I/ErbB signaling system in development and disease.发育与疾病中的神经调节蛋白-I/表皮生长因子受体信号系统
Adv Anat Embryol Cell Biol. 2007;190:1-65.
4
Signaling through ERBB receptors: multiple layers of diversity and control.通过ERBB受体的信号传导:多层次的多样性与调控。
Cell Signal. 2006 Jul;18(7):923-33. doi: 10.1016/j.cellsig.2005.12.007. Epub 2006 Feb 7.
5
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs):作用机制复杂的简单药物?
J Cell Physiol. 2003 Jan;194(1):13-9. doi: 10.1002/jcp.10194.
6
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.致癌性表皮生长因子受体2/表皮生长因子受体3异二聚体是表皮生长因子和β细胞素的替代受体。
Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642.
7
The ErbB/HER receptor protein-tyrosine kinases and cancer.表皮生长因子受体(ErbB/HER)蛋白酪氨酸激酶与癌症
Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. doi: 10.1016/j.bbrc.2004.04.150.
8
Bivalence of EGF-like ligands drives the ErbB signaling network.表皮生长因子样配体的二价性驱动着表皮生长因子受体(ErbB)信号网络。
EMBO J. 1997 Aug 15;16(16):4938-50. doi: 10.1093/emboj/16.16.4938.
9
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.表皮生长因子相关肽的可获得性会影响表皮生长因子受体靶向抗癌疗法的疗效。
Cancer Res. 2002 Jun 1;62(11):3151-8.
10
ErbB receptors and signaling pathways in cancer.癌症中的表皮生长因子受体(ErbB)及其信号通路
Curr Opin Cell Biol. 2009 Apr;21(2):177-84. doi: 10.1016/j.ceb.2008.12.010. Epub 2009 Feb 7.

引用本文的文献

1
METTL14 Hinders DCM Progression via Mediating the m6A Methylation of NRG4 in HG-Induced H9C2 Cells.METTL14通过介导高糖诱导的H9C2细胞中NRG4的m6A甲基化来抑制扩张型心肌病进展。
Mol Biotechnol. 2025 Sep 2. doi: 10.1007/s12033-025-01507-4.
2
Protective effect and mechanism of Sufentanil on acute lung injury in septic mice.舒芬太尼对脓毒症小鼠急性肺损伤的保护作用及机制
Front Pharmacol. 2025 Jan 16;15:1514602. doi: 10.3389/fphar.2024.1514602. eCollection 2024.
3
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
图卡替尼与曲妥珠单抗治疗HER2突变转移性乳腺癌:一项2期篮子试验
Nat Med. 2025 Mar;31(3):909-916. doi: 10.1038/s41591-024-03462-0. Epub 2025 Jan 17.
4
Peritoneal adipose stem cell-derived extracellular vesicles mediate the regulation of ovarian cancer cell proliferation and migration through EGFR-NF-κB signaling.腹膜脂肪干细胞衍生的细胞外囊泡通过表皮生长因子受体-核因子-κB信号通路介导对卵巢癌细胞增殖和迁移的调节。
Genes Dis. 2024 Mar 28;12(2):101283. doi: 10.1016/j.gendis.2024.101283. eCollection 2025 Mar.
5
A good response to furmonertinib fourth-line treatment of an advanced lung adenocarcinoma patient with EGFR exon20in and PIK3CA mutation: a case report and literature review.一名晚期肺腺癌患者,伴有EGFR外显子20插入和PIK3CA突变,对伏美替尼四线治疗反应良好:病例报告及文献综述
Front Oncol. 2024 Dec 17;14:1467722. doi: 10.3389/fonc.2024.1467722. eCollection 2024.
6
Proteomic analysis identifies novel biological pathways that may link dietary quality to type 2 diabetes risk: evidence from African American and Asian cohorts.蛋白质组学分析确定了可能将饮食质量与2型糖尿病风险联系起来的新生物途径:来自非裔美国人和亚洲人群队列的证据。
Am J Clin Nutr. 2025 Jan;121(1):100-110. doi: 10.1016/j.ajcnut.2024.11.016. Epub 2024 Nov 19.
7
Isothiocyanates attenuate heparin-induced proliferation of colon cancer cells in vitro.异硫氰酸盐在体外可减弱肝素诱导的结肠癌细胞增殖。
Food Sci Nutr. 2024 Aug 13;12(10):7842-7853. doi: 10.1002/fsn3.4296. eCollection 2024 Oct.
8
Lapatinib-induced enhancement of mitochondrial respiration in HER2-positive SK-BR-3 cells: mechanism revealed by analysis of proteomic but not transcriptomic data.拉帕替尼诱导HER2阳性SK-BR-3细胞线粒体呼吸增强:通过蛋白质组学而非转录组学数据分析揭示机制
Front Mol Biosci. 2024 Sep 30;11:1470496. doi: 10.3389/fmolb.2024.1470496. eCollection 2024.
9
Cross-omics strategies and personalised options for lung cancer immunotherapy.多组学策略与肺癌免疫治疗的个体化选择
Front Immunol. 2024 Sep 25;15:1471409. doi: 10.3389/fimmu.2024.1471409. eCollection 2024.
10
Discovery of potent allosteric antibodies inhibiting EGFR.发现强效变构抗体抑制 EGFR。
MAbs. 2024 Jan-Dec;16(1):2406548. doi: 10.1080/19420862.2024.2406548. Epub 2024 Sep 20.